206 related articles for article (PubMed ID: 29076612)
1. New Insights into SN-38 Glucuronidation: Evidence for the Important Role of UDP Glucuronosyltransferase 1A9.
Xiao L; Zhu L; Li W; Li C; Cao Y; Ge G; Sun X
Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):424-428. PubMed ID: 29076612
[TBL] [Abstract][Full Text] [Related]
2. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
[TBL] [Abstract][Full Text] [Related]
3. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
Rowland A; Knights KM; Mackenzie PI; Miners JO
Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
[TBL] [Abstract][Full Text] [Related]
4. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
[TBL] [Abstract][Full Text] [Related]
5. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
6. Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9.
Manevski N; Moreolo PS; Yli-Kauhaluoma J; Finel M
Drug Metab Dispos; 2011 Nov; 39(11):2117-29. PubMed ID: 21856742
[TBL] [Abstract][Full Text] [Related]
7. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
[TBL] [Abstract][Full Text] [Related]
9. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
[TBL] [Abstract][Full Text] [Related]
10. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.
Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T
Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316
[TBL] [Abstract][Full Text] [Related]
11. Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9.
Zhu L; Ge G; Liu Y; He G; Liang S; Fang Z; Dong P; Cao Y; Yang L
Xenobiotica; 2012 Oct; 42(10):1001-8. PubMed ID: 22591254
[TBL] [Abstract][Full Text] [Related]
12. Differential rates of glucuronidation for 7-ethyl-10-hydroxy-camptothecin (SN-38) lactone and carboxylate in human and rat microsomes and recombinant UDP-glucuronosyltransferase isoforms.
Tallman MN; Ritter JK; Smith PC
Drug Metab Dispos; 2005 Jul; 33(7):977-83. PubMed ID: 15833930
[TBL] [Abstract][Full Text] [Related]
13. Atypical Kinetics and Albumin Effect of Glucuronidation of 5-n-Butyl-4-{4-[2-(1H-tetrazole-5- yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6- dichlorophenyl)-3H-1,2,4-triazol-3-one, a Novel Nonpeptide Angiotensin Type 1 Receptor Antagonist, in Liver Microsomes and UDP-Glucuronosyl-transferase.
Peng Y; Zhang X; Zhu Y; Wu H; Gu S; Chang Q; Zhou Y; Wang G; Sun J
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562678
[TBL] [Abstract][Full Text] [Related]
14. Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation.
Loureiro AI; Fernandes-Lopes C; Bonifácio MJ; Wright LC; Soares-da-Silva P
Drug Metab Dispos; 2011 Sep; 39(9):1486-94. PubMed ID: 21673130
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.
Kerdpin O; Knights KM; Elliot DJ; Miners JO
Biochem Pharmacol; 2008 Jul; 76(2):249-57. PubMed ID: 18541222
[TBL] [Abstract][Full Text] [Related]
16. Regio- and isoform-specific glucuronidation of psoralidin: evaluation of 3-o-glucuronidation as a functional marker for UGT1A9.
Sun H; Ma Z; Lu D; Wu B
J Pharm Sci; 2015 Jul; 104(7):2369-77. PubMed ID: 25941108
[TBL] [Abstract][Full Text] [Related]
17. In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences.
Sun D; Zhu L; Xiao L; Xia Y; Ge G; Cao Y; Wu Y; Yin J; Yang L
Xenobiotica; 2014 Nov; 44(11):988-95. PubMed ID: 24916899
[TBL] [Abstract][Full Text] [Related]
18. The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver.
Girard H; Villeneuve L; Court MH; Fortier LC; Caron P; Hao Q; von Moltke LL; Greenblatt DJ; Guillemette C
Drug Metab Dispos; 2006 Jul; 34(7):1220-8. PubMed ID: 16595709
[TBL] [Abstract][Full Text] [Related]
19. Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes.
Yong WP; Ramirez J; Innocenti F; Ratain MJ
Clin Cancer Res; 2005 Sep; 11(18):6699-704. PubMed ID: 16166450
[TBL] [Abstract][Full Text] [Related]
20. The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1.
Fujita K; Sugiyama M; Akiyama Y; Ando Y; Sasaki Y
Cancer Chemother Pharmacol; 2011 Jan; 67(1):237-41. PubMed ID: 20814789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]